Calcific valvular disease in the elderly
In 1904, Monckebery first discovered that people would experience degeneration during the natural aging process, leading to calcified aortic stenosis (CAS). In 1910, Dewitsky first described mitral annular calcification (MAC) and believed that this calcification was caused by degeneration. Since then, pathologists and clinicians have systematically observed the age-related changes of heart valves and confirmed that calcific valvular heart disease is a senile disease caused by valve aging, degeneration and calcium deposition that increases with age. It is also called senile degenerative valvular disease or senile cardiac calcification syndrome.
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
Elderly population -
Related symptoms:
Fatigue Systolic murmur Cardiac enlargement Palpitations Calcification -
Concurrent disease:
Related Drugs
Nicorandil Tablets
Indication: It is suitable for the treatment of coronary heart disease and angina pectoris. It is effective for exertional, spontaneous, post-infarction or mixed angina pectoris. It can be used for patients with angina pectoris accompanied by atrial fibrillation, cardiac enlargement, and patients who need to use other anti-angina drugs with caution.
Manufacturer:
Topfond Pharmaceutical Co., Ltd.
Captopril Tablets
Indication: 1. Hypertension; 2. Heart failure.
Isosorbide mononitrate sustained-release capsules (IV)
Indication: Prevention and treatment of angina pectoris. Long-term treatment of coronary heart disease and myocardial infarction with persistent angina pectoris symptoms. Auxiliary treatment of chronic cor pulmonale and chronic congestive heart failure.
Digoxin tablets
Indication: Suitable for acute and chronic heart failure.
Related Ingredients